Long-term use of PPIs not linked to all-cause mortality or gastroenterology complications: AGA Jacinthlyn Sylvia8 July 2022 8:00 PM ISTUSA: In a new study conducted by Chun-Han Lo and the team it was shown that after controlling for protopathic bias, proton pump inhibitor (PPI) usage...
Regular and prolonged use of PPIs associated with higher risk of diabetes: Study Dr. Shravani Dali27 April 2022 10:45 AM ISTRegular and prolonged use of PPIs is associated with a higher risk of diabetes, according to a recent study published in The Journal of Clinical...
PPIs use improves survival in cirrhosis patients with prior GI bleeding, study shows Medha Baranwal13 April 2022 10:45 PM ISTUSA: A recent study has found that the use of proton pump inhibitors (PPIs) for people with prior gastrointestinal bleeding (GIB) is associated with...
Esomeprazole-prokinetic combination: A novel approach to managing GERD Dr. Shubham Vatsya27 Nov 2021 12:03 PM ISTGastroesophageal reflux disease (GERD) is emerging as a major health concern, having a strikingly high prevalence rate of 7.6% to...
Managing Night Time GERD: Comparative Review of Efficacy of esomeprazole against conventional PPIs Dr. Shubham Vatsya25 Oct 2021 12:45 PM ISTNight-time Gastroesophageal reflux disease (GERD) causing symptoms is now being identified as a distinct clinical entity (1). It is an...
Night-time GERD: Understanding the Role of Esomeprazole Dr. Shubham Vatsya24 Sept 2021 11:32 AM ISTGastro-oesophageal reflux disease (GERD) is a common chronic diseased state, with studies highlighting a global pooled prevalence rate of 13.98%,...
Prolonged use of PPI tied to community acquired pneumonia risk: Study MD Editorial Team8 Sept 2021 8:00 AM ISTPeople have dealt with stomach acid-related problems in a variety of ways.ProtienPump Inhibitors (PPI) include heavily marketed familiar brand-name...
Long term use of PPIs Increase the Risk of Biliary Tract Cancer: Study MD Bureau1 Jun 2021 8:45 AM ISTBiliary tract cancer is a heterogeneous group of aggressive malignant disorders constituting ~3% of all gastrointestinal malignancies. In a recent...
